{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:15:42Z","timestamp":1793330142760,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13244-019-0733-7","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T06:11:46Z","timestamp":1558419106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["An update on Burkitt lymphoma: a review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence"],"prefix":"10.1186","volume":"10","author":[{"given":"Kevin","family":"Kalisz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Alessandrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Kikano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil H.","family":"Ramaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sree Harsha","family":"Tirumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"issue":"6","key":"733_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ajh.23187","volume":"87","author":"SM Mbulaiteye","year":"2012","unstructured":"Mbulaiteye SM, Anderson WF, Ferlay J et al (2012) Pediatric, elderly, and emerging adult-onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa. Am J Hematol 87(6):573\u2013578. \n                    https:\/\/doi.org\/10.1002\/ajh.23187","journal-title":"Am J Hematol"},{"issue":"1","key":"733_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107(1):265\u2013276. \n                    https:\/\/doi.org\/10.1182\/blood-2005-06-2508","journal-title":"Blood"},{"issue":"4","key":"733_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1634\/theoncologist.11-4-375","volume":"11","author":"JA Ferry","year":"2006","unstructured":"Ferry JA (2006) Burkitt\u2019s lymphoma: clinicopathologic features and differential diagnosis. Oncologist 11(4):375\u2013383. \n                    https:\/\/doi.org\/10.1634\/theoncologist.11-4-375","journal-title":"Oncologist"},{"issue":"11","key":"733_CR4","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1002\/ijc.23800","volume":"123","author":"MD Ogwang","year":"2008","unstructured":"Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM (2008) Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer 123(11):2658\u20132663. \n                    https:\/\/doi.org\/10.1002\/ijc.23800","journal-title":"Int J Cancer"},{"issue":"6","key":"733_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1365-2141.2011.09013.x","volume":"156","author":"I Magrath","year":"2012","unstructured":"Magrath I (2012) Epidemiology: clues to the pathogenesis of Burkitt lymphoma. Br J Haematol 156(6):744\u2013756. \n                    https:\/\/doi.org\/10.1111\/j.1365-2141.2011.09013.x","journal-title":"Br J Haematol"},{"issue":"12","key":"733_CR6","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1136\/jcp.2007.047977","volume":"60","author":"G Brady","year":"2007","unstructured":"Brady G, MacArthur GJ, Farrell PJ (2007) Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol 60(12):1397\u20131402. \n                    https:\/\/doi.org\/10.1136\/jcp.2007.047977","journal-title":"J Clin Pathol"},{"issue":"2","key":"733_CR7","doi-asserted-by":"publisher","first-page":"a014282","DOI":"10.1101\/cshperspect.a014282","volume":"4","author":"R. Schmitz","year":"2014","unstructured":"Schmitz R, Ceribelli M, Pittaluga S, Wright G, Staudt LM (2014) Oncogenic mechanisms in Burkitt lymphoma. Cold Spring Harb Perspect Med 4(2). \n                    https:\/\/doi.org\/10.1101\/cshperspect.a014282","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"9","key":"733_CR8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.5858\/arpa.2014-0451-CP","volume":"139","author":"DP O\u2019Malley","year":"2015","unstructured":"O\u2019Malley DP, Auerbach A, Weiss LM (2015) Practical applications in immunohistochemistry: evaluation of diffuse large B-cell lymphoma and related large B-cell lymphomas. Arch Pathol Lab Med 139(9):1094\u20131107. \n                    https:\/\/doi.org\/10.5858\/arpa.2014-0451-CP","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"733_CR9","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/blood-2016-02-636316","volume":"129","author":"P Sesques","year":"2017","unstructured":"Sesques P, Johnson NA (2017) Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and\/or BCL6 rearrangements. Blood 129(3):280\u2013288. \n                    https:\/\/doi.org\/10.1182\/blood-2016-02-636316","journal-title":"Blood"},{"issue":"20","key":"733_CR10","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. \n                    https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"issue":"4","key":"733_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/jcu.1870070408","volume":"7","author":"TH Shawker","year":"1979","unstructured":"Shawker TH, Dunnick NR, Head GL, Magrath IT (1979) Ultrasound evaluation of American Burkitt\u2019s lymphoma. J Clin Ultrasound 7(4):279\u2013283","journal-title":"J Clin Ultrasound"},{"issue":"5","key":"733_CR12","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.2214\/AJR.08.1476","volume":"192","author":"DM Biko","year":"2009","unstructured":"Biko DM, Anupindi SA, Hernandez A, Kersun L, Bellah R (2009) Childhood Burkitt lymphoma: abdominal and pelvic imaging findings. AJR Am J Roentgenol 192(5):1304\u20131315. \n                    https:\/\/doi.org\/10.2214\/AJR.08.1476","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"733_CR13","doi-asserted-by":"publisher","first-page":"W384","DOI":"10.2214\/AJR.10.5692","volume":"197","author":"J Gu","year":"2011","unstructured":"Gu J, Chan T, Zhang J, Leung AY, Kwong YL, Khong PL (2011) Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. AJR Am J Roentgenol 197(3):W384\u2013W391. \n                    https:\/\/doi.org\/10.2214\/AJR.10.5692","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"733_CR14","doi-asserted-by":"publisher","first-page":"e0161386","DOI":"10.1371\/journal.pone.0161386","volume":"11","author":"S Schob","year":"2016","unstructured":"Schob S, Meyer J, Gawlitza M et al (2016) Diffusion-weighted MRI reflects proliferative activity in primary CNS lymphoma. PLoS One 11(8):e0161386. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0161386","journal-title":"PLoS One"},{"issue":"11","key":"733_CR15","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-14-2454","volume":"21","author":"ME Mayerhoefer","year":"2015","unstructured":"Mayerhoefer ME, Karanikas G, Kletter K et al (2015) Evaluation of diffusion-weighted magnetic resonance imaging for follow-up and treatment response assessment of lymphoma: results of an 18F-FDG-PET\/CT-controlled prospective study in 64 patients. Clin Cancer Res 21(11):2506\u20132513. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2454","journal-title":"Clin Cancer Res"},{"issue":"2","key":"733_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/10428194.2018.1482541","volume":"60","author":"Domenico Albano","year":"2018","unstructured":"Albano D, Bosio G, Re A, Pagani C, Giubbini R, Bertagna F (2018) Metabolic behavior and prognostic value of early and end of treatment 18F-FDG PET\/CT in adult Burkitt\u2019s lymphoma: the role of Deauville and IHP criteria. Leuk Lymphoma:1\u20138. \n                    https:\/\/doi.org\/10.1080\/10428194.2018.1482541","journal-title":"Leukemia & Lymphoma"},{"issue":"1","key":"733_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00259-018-4173-2","volume":"46","author":"D Albano","year":"2019","unstructured":"Albano D, Bosio G, Pagani C et al (2019) Prognostic role of baseline 18F-FDG PET\/CT metabolic parameters in Burkitt lymphoma. Eur J Nucl Med Mol Imaging 46(1):87\u201396. \n                    https:\/\/doi.org\/10.1007\/s00259-018-4173-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"733_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fmed.2014.00054","volume":"1","author":"C Bailly","year":"2014","unstructured":"Bailly C, Eugene T, Couec ML et al (2014) Prognostic value and clinical impact of (18) FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapy. Front Med (Lausanne) 1:54. \n                    https:\/\/doi.org\/10.3389\/fmed.2014.00054","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"733_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/ejh.12284","volume":"94","author":"E Carrillo-Cruz","year":"2015","unstructured":"Carrillo-Cruz E, Marin-Oyaga VA, Sole Rodriguez M et al (2015) Role of 18F-FDG-PET\/CT in the management of Burkitt lymphoma. Eur J Haematol 94(1):23\u201330. \n                    https:\/\/doi.org\/10.1111\/ejh.12284","journal-title":"Eur J Haematol"},{"issue":"9","key":"733_CR20","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1007\/s00261-017-1454-3","volume":"43","author":"T Davidson","year":"2018","unstructured":"Davidson T, Priel E, Schiby G et al (2018) Low rate of spleen involvement in sporadic Burkitt lymphoma at staging on PET-CT. Abdom Radiol (NY) 43(9):2369\u20132374. \n                    https:\/\/doi.org\/10.1007\/s00261-017-1454-3","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"733_CR21","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1016\/j.ejrad.2009.07.035","volume":"75","author":"D Karantanis","year":"2010","unstructured":"Karantanis D, Durski JM, Lowe VJ et al (2010) 18F-FDG PET and PET\/CT in Burkitt\u2019s lymphoma. Eur J Radiol 75(1):e68\u2013e73. \n                    https:\/\/doi.org\/10.1016\/j.ejrad.2009.07.035","journal-title":"Eur J Radiol"},{"issue":"12","key":"733_CR22","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1186\/s40880-015-0057-z","volume":"34","author":"WX Wei","year":"2015","unstructured":"Wei WX, Huang JJ, Li WY et al (2015) Prognostic values of interim and post-therapy 18F-FDG PET\/CT scanning in adult patients with Burkitt\u2019s lymphoma. Chin J Cancer 34(12):608\u2013613. \n                    https:\/\/doi.org\/10.1186\/s40880-015-0057-z","journal-title":"Chin J Cancer"},{"issue":"4","key":"733_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3109\/10428194.2012.727416","volume":"54","author":"G Cheng","year":"2013","unstructured":"Cheng G, Servaes S, Zhuang H (2013) Value of (18) F-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma. Leuk Lymphoma 54(4):737\u2013742. \n                    https:\/\/doi.org\/10.3109\/10428194.2012.727416","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"733_CR24","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2214\/AJR.14.13181","volume":"204","author":"L Heacock","year":"2015","unstructured":"Heacock L, Weissbrot J, Raad R et al (2015) PET\/MRI for the evaluation of patients with lymphoma: initial observations. AJR Am J Roentgenol 204(4):842\u2013848. \n                    https:\/\/doi.org\/10.2214\/AJR.14.13181","journal-title":"AJR Am J Roentgenol"},{"key":"733_CR25","volume-title":"NCCN clinical practice guidelines: B-cell lymphomas version 1.2019","author":"A Zelenetz","year":"2018","unstructured":"Zelenetz A, Gordon L, J. A, A. R (2018) NCCN clinical practice guidelines: B-cell lymphomas version 1.2019"},{"issue":"3","key":"733_CR26","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1182\/blood-2018-04-844472","volume":"132","author":"S Gopal","year":"2018","unstructured":"Gopal S, Gross TG (2018) How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa. Blood 132(3):254\u2013263. \n                    https:\/\/doi.org\/10.1182\/blood-2018-04-844472","journal-title":"Blood"},{"issue":"1","key":"733_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00259-018-4103-3","volume":"46","author":"CN Burggraaff","year":"2019","unstructured":"Burggraaff CN, de Jong A, Hoekstra OS et al (2019) Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 46(1):65\u201379. \n                    https:\/\/doi.org\/10.1007\/s00259-018-4103-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"733_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2214\/ajr.132.1.1","volume":"132","author":"NR Dunnick","year":"1979","unstructured":"Dunnick NR, Reaman GH, Head GL, Shawker TH, Ziegler JL (1979) Radiographic manifestations of Burkitt\u2019s lymphoma in American patients. AJR Am J Roentgenol 132(1):1\u20136. \n                    https:\/\/doi.org\/10.2214\/ajr.132.1.1","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"733_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00383-011-2982-5","volume":"28","author":"RJ England","year":"2012","unstructured":"England RJ, Pillay K, Davidson A, Numanoglu A, Millar AJ (2012) Intussusception as a presenting feature of Burkitt lymphoma: implications for management and outcome. Pediatr Surg Int 28(3):267\u2013270. \n                    https:\/\/doi.org\/10.1007\/s00383-011-2982-5","journal-title":"Pediatr Surg Int"},{"issue":"3","key":"733_CR30","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00247-008-1063-y","volume":"39","author":"S Wong","year":"2009","unstructured":"Wong S, Sanchez TR, Swischuk LE, Huang FS (2009) Diffuse peritoneal lymphomatosis: atypical presentation of Burkitt lymphoma. Pediatr Radiol 39(3):274\u2013276. \n                    https:\/\/doi.org\/10.1007\/s00247-008-1063-y","journal-title":"Pediatr Radiol"},{"issue":"4","key":"733_CR31","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s00247-012-2559-z","volume":"43","author":"R Kluge","year":"2013","unstructured":"Kluge R, Kurch L, Montravers F, Mauz-Korholz C (2013) FDG PET\/CT in children and adolescents with lymphoma. Pediatr Radiol 43(4):406\u2013417. \n                    https:\/\/doi.org\/10.1007\/s00247-012-2559-z","journal-title":"Pediatr Radiol"},{"issue":"5","key":"733_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/BF02388050","volume":"18","author":"DA Nzeh","year":"1988","unstructured":"Nzeh DA (1988) Atypical intrathoracic manifestations of Burkitt\u2019s lymphoma. Pediatr Radiol 18(5):411\u2013412","journal-title":"Pediatr Radiol"},{"key":"733_CR33","doi-asserted-by":"publisher","first-page":"553","DOI":"10.12659\/AJCR.899022","volume":"17","author":"O Chan","year":"2016","unstructured":"Chan O, Igwe M, Breburda CS, Amar S (2016) Burkitt lymphoma presenting as an intracardiac mass: case report and review of literature. Am J Case Rep 17:553\u2013558","journal-title":"Am J Case Rep"},{"issue":"5","key":"733_CR34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.ijporl.2013.03.012","volume":"77","author":"T Kobayashi","year":"2013","unstructured":"Kobayashi T, Hyodo M, Honda N (2013) Primary endobronchial Burkitt\u2019s lymphoma in a child: a case report. Int J Pediatr Otorhinolaryngol 77(5):875\u2013878. \n                    https:\/\/doi.org\/10.1016\/j.ijporl.2013.03.012","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"733_CR35","doi-asserted-by":"publisher","first-page":"746098","DOI":"10.1155\/2012\/746098","volume":"2012","author":"R Lu","year":"2012","unstructured":"Lu R (2012) Primary burkitt lymphoma of the chest wall. Case Rep Hematol 2012:746098. \n                    https:\/\/doi.org\/10.1155\/2012\/746098","journal-title":"Case Rep Hematol"},{"key":"733_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1749-8090-2-30","volume":"2","author":"P Kaul","year":"2007","unstructured":"Kaul P, Javangula K (2007) Burkitt lymphoma masquerading as cardiac tamponade. J Cardiothorac Surg 2:30. \n                    https:\/\/doi.org\/10.1186\/1749-8090-2-30","journal-title":"J Cardiothorac Surg"},{"issue":"12","key":"733_CR37","first-page":"1188","volume":"17","author":"G Janbabai","year":"2012","unstructured":"Janbabai G, Kayedimajd S, Alian S, Naghshvar F, Rashidi M, Farazmandfar T (2012) Bilateral breast swelling in a 23-year-old woman with Burkitt lymphoma. J Res Med Sci 17(12):1188\u20131191","journal-title":"J Res Med Sci"},{"key":"733_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/AHMT.S94170","volume":"8","author":"M Dozzo","year":"2017","unstructured":"Dozzo M, Carobolante F, Donisi PM et al (2017) Burkitt lymphoma in adolescents and young adults: management challenges. Adolesc Health Med Ther 8:11\u201329. \n                    https:\/\/doi.org\/10.2147\/AHMT.S94170","journal-title":"Adolesc Health Med Ther"},{"issue":"1","key":"733_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5152\/dir.2015.15211","volume":"22","author":"BE Derinkuyu","year":"2016","unstructured":"Derinkuyu BE, Boyunaga O, Oztunali C et al (2016) Imaging features of Burkitt lymphoma in pediatric patients. Diagn Interv Radiol 22(1):95\u2013100. \n                    https:\/\/doi.org\/10.5152\/dir.2015.15211","journal-title":"Diagn Interv Radiol"},{"key":"733_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12907-016-0028-6","volume":"16","author":"M Allaoui","year":"2016","unstructured":"Allaoui M, Benchafai I, Mahtat el M et al (2016) Primary Burkitt lymphoma of the thyroid gland: case report of an exceptional type of thyroid neoplasm and review of the literature. BMC Clin Pathol 16:6. \n                    https:\/\/doi.org\/10.1186\/s12907-016-0028-6","journal-title":"BMC Clin Pathol"},{"issue":"10","key":"733_CR41","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","volume":"104","author":"KA Blum","year":"2004","unstructured":"Blum KA, Lozanski G, Byrd JC (2004) Adult Burkitt leukemia and lymphoma. Blood 104(10):3009\u20133020. \n                    https:\/\/doi.org\/10.1182\/blood-2004-02-0405","journal-title":"Blood"},{"issue":"27","key":"733_CR42","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068. \n                    https:\/\/doi.org\/10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"issue":"4","key":"733_CR43","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3109\/10428194.2015.1085529","volume":"57","author":"JY Song","year":"2016","unstructured":"Song JY, Venkataraman G, Fedoriw Y et al (2016) Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults. Leuk Lymphoma 57(4):866\u2013871. \n                    https:\/\/doi.org\/10.3109\/10428194.2015.1085529","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"733_CR44","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/0022-3468(91)90596-L","volume":"26","author":"JE Stein","year":"1991","unstructured":"Stein JE, Schwenn MR, Jacir NN, Harris BH (1991) Surgical restraint in Burkitt\u2019s lymphoma in children. J Pediatr Surg 26(11):1273\u20131275","journal-title":"J Pediatr Surg"},{"issue":"19","key":"733_CR45","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1182\/blood-2014-06-538504","volume":"124","author":"C Jacobson","year":"2014","unstructured":"Jacobson C, LaCasce A (2014) How I treat Burkitt lymphoma in adults. Blood 124(19):2913\u20132920. \n                    https:\/\/doi.org\/10.1182\/blood-2014-06-538504","journal-title":"Blood"},{"issue":"7","key":"733_CR46","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/annonc\/mdh262","volume":"15","author":"S Smeland","year":"2004","unstructured":"Smeland S, Blystad AK, Kvaloy SO et al (2004) Treatment of Burkitt\u2019s\/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian radium hospital with the use of three successive regimens. Ann Oncol 15(7):1072\u20131078. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdh262","journal-title":"Ann Oncol"},{"issue":"10036","key":"733_CR47","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1016\/S0140-6736(15)01317-3","volume":"387","author":"V Ribrag","year":"2016","unstructured":"Ribrag V, Koscielny S, Bosq J et al (2016) Rituximab and dose-dense chemotherapy for adults with Burkitt\u2019s lymphoma: a randomised, controlled, open-label, phase 3 trial. Lancet 387(10036):2402\u20132411. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(15)01317-3","journal-title":"Lancet"},{"issue":"6","key":"733_CR48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.blre.2006.02.001","volume":"20","author":"QA Hill","year":"2006","unstructured":"Hill QA, Owen RG (2006) CNS prophylaxis in lymphoma: who to target and what therapy to use. Blood Rev 20(6):319\u2013332. \n                    https:\/\/doi.org\/10.1016\/j.blre.2006.02.001","journal-title":"Blood Rev"},{"issue":"6","key":"733_CR49","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1200\/JCO.1986.4.6.847","volume":"4","author":"JI Bernstein","year":"1986","unstructured":"Bernstein JI, Coleman CN, Strickler JG, Dorfman RF, Rosenberg SA (1986) Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt\u2019s and non-Burkitt\u2019s types). J Clin Oncol 4(6):847\u2013858. \n                    https:\/\/doi.org\/10.1200\/JCO.1986.4.6.847","journal-title":"J Clin Oncol"},{"issue":"11","key":"733_CR50","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1200\/JCO.1983.1.11.677","volume":"1","author":"E Sariban","year":"1983","unstructured":"Sariban E, Edwards B, Janus C, Magrath I (1983) Central nervous system involvement in American Burkitt\u2019s lymphoma. J Clin Oncol 1(11):677\u2013681. \n                    https:\/\/doi.org\/10.1200\/JCO.1983.1.11.677","journal-title":"J Clin Oncol"},{"issue":"3","key":"733_CR51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3109\/08880018.2013.834400","volume":"31","author":"HM Eissa","year":"2014","unstructured":"Eissa HM, Allen CE, Kamdar K et al (2014) Pediatric Burkitt\u2019s lymphoma and diffuse B-cell lymphoma: are surveillance scans required? Pediatr Hematol Oncol 31(3):253\u2013257. \n                    https:\/\/doi.org\/10.3109\/08880018.2013.834400","journal-title":"Pediatr Hematol Oncol"},{"issue":"24","key":"733_CR52","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1182\/blood-2012-12-475558","volume":"121","author":"LJ Costa","year":"2013","unstructured":"Costa LJ, Xavier AC, Wahlquist AE, Hill EG (2013) Trends in survival of patients with Burkitt lymphoma\/leukemia in the USA: an analysis of 3691 cases. Blood 121(24):4861\u20134866. \n                    https:\/\/doi.org\/10.1182\/blood-2012-12-475558","journal-title":"Blood"},{"issue":"4","key":"733_CR53","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4143\/crt.2013.047","volume":"46","author":"H Kim","year":"2014","unstructured":"Kim H, Park ES, Lee SH et al (2014) Clinical outcome of relapsed or refractory Burkitt lymphoma and mature B-cell lymphoblastic leukemia in children and adolescents. Cancer Res Treat 46(4):358\u2013365. \n                    https:\/\/doi.org\/10.4143\/crt.2013.047","journal-title":"Cancer Res Treat"},{"issue":"1","key":"733_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1148\/radiol.10092129","volume":"258","author":"JM Torrisi","year":"2011","unstructured":"Torrisi JM, Schwartz LH, Gollub MJ, Ginsberg MS, Bosl GJ, Hricak H (2011) CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. Radiology 258(1):41\u201356. \n                    https:\/\/doi.org\/10.1148\/radiol.10092129","journal-title":"Radiology"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-019-0733-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13244-019-0733-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-019-0733-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T19:05:51Z","timestamp":1589915151000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-019-0733-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["733"],"URL":"https:\/\/doi.org\/10.1186\/s13244-019-0733-7","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]},"assertion":[{"value":"15 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"56"}}